Craig Dais Power - 10 Nov 2023 Form 4 Insider Report for NAVIDEA BIOPHARMACEUTICALS, INC.

Reporting relationship: CHIEF FINANCIAL OFFICER
Issuer ticker: N/A
Reported as of: 10 Nov 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 Nov 2023, 16:38:55 UTC
Prior SEC filing: 15 Aug 2023
Source filing: View source filing
Reporting owner signature: /s/ Gioia Gentile for Craig Dais by power of attorney

Key filing fact

Craig Dais Power filed Form 4 for NAVIDEA BIOPHARMACEUTICALS, INC. on 14 Nov 2023.

Key facts

This page summarizes Craig Dais Power's Form 4 filing for NAVIDEA BIOPHARMACEUTICALS, INC..
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 14 Nov 2023, 16:38.

Change

Previous filing in this sequence was filed on 15 Aug 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NAVB transaction

Common Stock

Award

Transaction value: $0
Shares: +973,633
Change %
Price: $0.000000
Shares after: 973,633
Date: 10 Nov 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Shares of stock vest in two tranches: 50% vest upon the date of the grant and the remaining 50% shall vest upon the one-year anniversary of the grant date, subject to Mr. Dais' continued employment with the Company.